|
Tatyana joined the Technology Partners life sciences investment team in 2007, bringing an extensive background in industry, finance and government specific to the healthcare industry.
Prior to joining Technology Partners, Tatyana spent several years with Pfizer in positions of increasing responsibility focused on strategy, business development and clinical trial acceleration, where she managed an innovative clinical trial program that achieves significantly faster clinical trial timelines. In addition, Tatyana led a physician segmentation strategy for Johnson & Johnson's interventional cardiology division.
Previously, Tatyana provided investment research coverage for emerging and established medical device companies, including MiniMed, VISX, Summit Autonomous, American Medical Systems and Guidant at Hambrecht & Quist (and its successor firms Chase H&Q and JPMorgan) as well as spearheaded coverage of the ophthalmology sector. Tatyana began her Wall Street career at Salomon Smith Barney, where she originated and executed transactions raising $12 billion on behalf of clients. She also served as a Capital Markets Advisor for the U.S. Department of Health & Human Services' Centers for Medicare and Medicaid Services.
Tatyana earned an MBA from Harvard Business School, where she and her team won the prestigious Business Plan Contest and a B.S. with honors from Carnegie Mellon University. She has studied art at the International School of Painting, Drawing, and Sculpture in Italy.
Tatyana can be reached at:
tatyana@technologypartners.com
|
